These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26254839)

  • 1. Antenatal Magnesium and Cerebral Palsy in Preterm Infants.
    Hirtz DG; Weiner SJ; Bulas D; DiPietro M; Seibert J; Rouse DJ; Mercer BM; Varner MW; Reddy UM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; Carpenter MW; O'Sullivan MJ; Peaceman AM; Hankins GD; Dudley D; Caritis SN;
    J Pediatr; 2015 Oct; 167(4):834-839.e3. PubMed ID: 26254839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage.
    Leviton A; Paneth N; Susser M; Reuss ML; Allred EN; Kuban K; Sanocka U; Hegyi T; Hiatt M; Shahrivar F; Van Marter LJ
    Pediatrics; 1997 Apr; 99(4):E2. PubMed ID: 9099777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines.
    Zeng X; Xue Y; Tian Q; Sun R; An R
    Medicine (Baltimore); 2016 Jan; 95(1):e2451. PubMed ID: 26735551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
    Bachnas MA; Mose JC; Effendi JS; Andonotopo W
    J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
    Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
    BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial.
    Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD;
    BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
    Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
    PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis.
    Wolf HT; Huusom LD; Henriksen TB; Hegaard HK; Brok J; Pinborg A
    BJOG; 2020 Sep; 127(10):1180-1188. PubMed ID: 32237069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage.
    Allan WC; Vohr B; Makuch RW; Katz KH; Ment LR
    Arch Pediatr Adolesc Med; 1997 Jun; 151(6):580-5. PubMed ID: 9193243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Palsy in Very Preterm Infants: A Nine-Year Prospective Study in a French Population-Based Tertiary Center.
    Chollat C; Bertrand E; Petit-Ledo A; de Vansay C; Voisin C; Dabaj I; Gillibert A; Marret S;
    J Pediatr; 2021 Oct; 237():183-189.e6. PubMed ID: 34144033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada.
    De Silva DA; Synnes AR; von Dadelszen P; Lee T; Bone JN; ; Magee LA
    Implement Sci; 2018 Jan; 13(1):8. PubMed ID: 29325592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE cohort study.
    Ancel PY; Livinec F; Larroque B; Marret S; Arnaud C; Pierrat V; Dehan M; N'Guyen S; Escande B; Burguet A; Thiriez G; Picaud JC; André M; Bréart G; Kaminski M;
    Pediatrics; 2006 Mar; 117(3):828-35. PubMed ID: 16510664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate.
    Cuff RD; Sullivan SA; Chang EY
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. The Neonatal Brain Hemorrhage Study Analysis Group.
    Paneth N; Jetton J; Pinto-Martin J; Susser M
    Pediatrics; 1997 May; 99(5):E1. PubMed ID: 9113958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental and Behavioral Outcomes in Extremely Premature Neonates With Ventriculomegaly in the Absence of Periventricular-Intraventricular Hemorrhage.
    Pappas A; Adams-Chapman I; Shankaran S; McDonald SA; Stoll BJ; Laptook AR; Carlo WA; Van Meurs KP; Hintz SR; Carlson MD; Brumbaugh JE; Walsh MC; Wyckoff MH; Das A; Higgins RD;
    JAMA Pediatr; 2018 Jan; 172(1):32-42. PubMed ID: 29181530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
    Nelson KB; Grether JK
    Pediatrics; 1995 Feb; 95(2):263-9. PubMed ID: 7838646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
    Lorthe E; Torchin H; Delorme P; Ancel PY; Marchand-Martin L; Foix-L'Hélias L; Benhammou V; Gire C; d'Ercole C; Winer N; Sentilhes L; Subtil D; Goffinet F; Kayem G
    Am J Obstet Gynecol; 2018 Sep; 219(3):298.e1-298.e14. PubMed ID: 29852153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
    Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraventricular hemorrhage and periventricular leukomalacia in preterm infants.
    Vergani P; Locatelli A; Doria V; Assi F; Paterlini G; Pezzullo JC; Ghidini A
    Obstet Gynecol; 2004 Aug; 104(2):225-31. PubMed ID: 15291991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.